Marblegate Capital MGTE
OTC MGTE
$1.00 -0.10 (-9.09%)
At close: Sep 8, 2026 · 4:00 PM EDT

Marblegate Capital (MGTE) Capital Expenditures (2024 - 2025)

Marblegate Capital's (MGTE) quarterly Capital Expenditures came in at -$20.5 million in Q4 2025, down 6014.03% on a YoY basis from $346329.0 in Q4 2024, and down 198.9% quarter-over-quarter from $20.7 million in Q3 2025.

Analysis

Marblegate Capital (MGTE) Capital Expenditures (2024 - 2025) Analysis & Trends

Marblegate Capital (MGTE) has reported Capital Expenditures for 2 consecutive years, with -$20.5 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures fell 6014.03% year-over-year to -$20.5 million; the trailing twelve-month figure through Dec 2025 stood at $227000.0 (changed N/A YoY), and the FY2025 full-year result was $247000.0, changed N/A from the prior year.
  • Capital Expenditures fell to -$20.5 million in Q4 2025 per MGTE's latest filing, from $20.7 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $20.7 million in Q3 2025 and bottomed at -$20.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Orix 43.64 Bn 43.64 Bn 4.68 Bn -
2 Royalty Pharma 26.15 Bn 25.32 Bn - 251.02 Mn
3 Royal Gold 21.54 Bn 21.36 Bn 390.45 Mn -
4 OR Royalties 6.72 Bn 6.64 Bn 82.22 Mn -
5 Encore Capital 2.11 Bn 1.93 Bn 455.04 Mn 440.84 Mn
6 Atlanticus Holdings 1.41 Bn 857.38 Mn 686.46 Mn 68,000.00
7 Jefferson Capital 1.18 Bn 1.15 Bn - -
8 Upbound 1.06 Bn 953.54 Mn 594.84 Mn 15.50 Mn
9 Lufax Holding 1.05 Bn -1.58 Bn - -
10 Marblegate Capital 76.87 Mn 68.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -20.48 Mn
Sep 30, 2025 20.71 Mn
Dec 31, 2024 -335,000.00
Sep 30, 2024 335,000.00